167 related articles for article (PubMed ID: 20187294)
1. E2F1 represses beta-catenin/TCF activity by direct up-regulation of Siah1.
Xie W; Jin L; Mei Y; Wu M
J Cell Mol Med; 2009 Aug; 13(8B):1719-1727. PubMed ID: 20187294
[TBL] [Abstract][Full Text] [Related]
2. e2f1 Gene is a new member of Wnt/beta-catenin/Tcf-regulated genes.
Abramova MV; Zatulovskiy EA; Svetlikova SB; Kukushkin AN; Pospelov VA
Biochem Biophys Res Commun; 2010 Jan; 391(1):142-6. PubMed ID: 19900401
[TBL] [Abstract][Full Text] [Related]
3. E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8.
Morris EJ; Ji JY; Yang F; Di Stefano L; Herr A; Moon NS; Kwon EJ; Haigis KM; Näär AM; Dyson NJ
Nature; 2008 Sep; 455(7212):552-6. PubMed ID: 18794899
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel T cell factor 4 (TCF-4) binding sites on the HIV long terminal repeat which associate with TCF-4, β-catenin, and SMAR1 to repress HIV transcription.
Henderson LJ; Narasipura SD; Adarichev V; Kashanchi F; Al-Harthi L
J Virol; 2012 Sep; 86(17):9495-503. PubMed ID: 22674979
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 overexpression in PhIP-induced colon tumors: cloning of the rat Bcl-2 promoter and characterization of a pathway involving beta-catenin, c-Myc and E2F1.
Li Q; Dashwood WM; Zhong X; Nakagama H; Dashwood RH
Oncogene; 2007 Sep; 26(42):6194-202. PubMed ID: 17404573
[TBL] [Abstract][Full Text] [Related]
6. TRAF4, a new substrate of SIAH1, participates in chemotherapy resistance of breast cancer cell by counteracting SIAH1-mediated downregulation of β-catenin.
Ren H; Mi X; Zhao P; Zhao X; Wei N; Huang H; Meng Z; Kou J; Sun M; Liu Y; Zhang H; Yang J; Li W; Li H
Breast Cancer Res Treat; 2020 Sep; 183(2):275-289. PubMed ID: 32671611
[TBL] [Abstract][Full Text] [Related]
7. TIS7 regulation of the beta-catenin/Tcf-4 target gene osteopontin (OPN) is histone deacetylase-dependent.
Vietor I; Kurzbauer R; Brosch G; Huber LA
J Biol Chem; 2005 Dec; 280(48):39795-801. PubMed ID: 16204248
[TBL] [Abstract][Full Text] [Related]
8. SIAH1 causes growth arrest and apoptosis in hepatoma cells through beta-catenin degradation-dependent and -independent mechanisms.
Yoshibayashi H; Okabe H; Satoh S; Hida K; Kawashima K; Hamasu S; Nomura A; Hasegawa S; Ikai I; Sakai Y
Oncol Rep; 2007 Mar; 17(3):549-56. PubMed ID: 17273732
[TBL] [Abstract][Full Text] [Related]
9. Streptonigrin inhibits β-Catenin/Tcf signaling and shows cytotoxicity in β-catenin-activated cells.
Park S; Chun S
Biochim Biophys Acta; 2011 Dec; 1810(12):1340-5. PubMed ID: 21763403
[TBL] [Abstract][Full Text] [Related]
10. The nuclear protein UHRF2 is a direct target of the transcription factor E2F1 in the induction of apoptosis.
Lu H; Hallstrom TC
J Biol Chem; 2013 Aug; 288(33):23833-43. PubMed ID: 23833190
[TBL] [Abstract][Full Text] [Related]
11. beta-Catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma.
Yan S; Zhou C; Zhang W; Zhang G; Zhao X; Yang S; Wang Y; Lu N; Zhu H; Xu N
Cancer Lett; 2008 Nov; 271(1):85-97. PubMed ID: 18602747
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of livin by beta-catenin/TCF signaling in human lung cancer cell lines.
Yuan D; Liu L; Gu D
Mol Cell Biochem; 2007 Dec; 306(1-2):171-8. PubMed ID: 17660948
[TBL] [Abstract][Full Text] [Related]
14. E2F1 suppresses Wnt/β-catenin activity through transactivation of β-catenin interacting protein ICAT.
Wu Z; Zheng S; Li Z; Tan J; Yu Q
Oncogene; 2011 Sep; 30(37):3979-84. PubMed ID: 21532622
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of E-cadherin is an essential event in activating beta-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells.
Wang Q; Sun ZX; Allgayer H; Yang HS
Oncogene; 2010 Jan; 29(1):128-38. PubMed ID: 19784072
[TBL] [Abstract][Full Text] [Related]
16. The intestine-specific transcription factor Cdx2 inhibits beta-catenin/TCF transcriptional activity by disrupting the beta-catenin-TCF protein complex.
Guo RJ; Funakoshi S; Lee HH; Kong J; Lynch JP
Carcinogenesis; 2010 Feb; 31(2):159-66. PubMed ID: 19734199
[TBL] [Abstract][Full Text] [Related]
17. Stage-specific control of connective tissue growth factor (CTGF/CCN2) expression in chondrocytes by Sox9 and beta-catenin.
Huang BL; Brugger SM; Lyons KM
J Biol Chem; 2010 Sep; 285(36):27702-12. PubMed ID: 20571031
[TBL] [Abstract][Full Text] [Related]
18. Rac1 GTPase and the Rac1 exchange factor Tiam1 associate with Wnt-responsive promoters to enhance beta-catenin/TCF-dependent transcription in colorectal cancer cells.
Buongiorno P; Pethe VV; Charames GS; Esufali S; Bapat B
Mol Cancer; 2008 Sep; 7():73. PubMed ID: 18826597
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis signal-regulating kinase 1 is a direct target of E2F1 and contributes to histone deacetylase inhibitor-induced apoptosis through positive feedback regulation of E2F1 apoptotic activity.
Tan J; Zhuang L; Jiang X; Yang KK; Karuturi KM; Yu Q
J Biol Chem; 2006 Apr; 281(15):10508-15. PubMed ID: 16476732
[TBL] [Abstract][Full Text] [Related]
20. Modulation of beta-catenin-mediated TCF-signalling in prostate cancer cell lines by wild-type and mutant p53.
Prowald A; Cronauer MV; von Klot C; Eilers T; Rinnab L; Herrmann T; Spindler KD; Montenarh M; Jonas U; Burchardt M
Prostate; 2007 Dec; 67(16):1751-60. PubMed ID: 17929268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
